Julia Rey

33 papers receiving 819 citations

Julia Rey's Hit Papers

Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response 2022 · 200 citations
2000+1+2Years since publication50100150200

Peers

Julia Rey
Comparison fields: 5 of 84
  • Biochemistry 163
  • Cancer Research 179
  • Medical Laboratory Technology 9
  • Hematology 102
  • Oncology 130
Replace Pimlak Charoenkwan with:
Pimlak Charoenkwan Thailand
Torben Pottgießer Germany
Zafer Arık Türkiye
Jingyan Tang China
Johannes Donauer Germany
Ròbert Póka Hungary
Rodrigo Sánchez-Bayona Spain
Anouar Fanidi France
Lirong Qu United States
Stefanos Zervoudis Greece
Julia Rey relative to Pimlak Charoenkwan Thailand Pimlak Charoenkwan's profile →
Citations per field
00.5×2×4×6×8.6×
Pimlak Charoenkwan · 1×
Citations per year

Countries citing papers authored by Julia Rey

Since Specialization
Citations

This map shows the geographic impact of Julia Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Rey more than expected).

Fields of papers citing papers by Julia Rey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Rey. The network helps show where Julia Rey may publish in the future.

Co-authors

The 25 scholars most cited alongside Julia Rey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julia Rey Line = papers co-authored together Julia Rey links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
Hit paper breakdown →
2022200
2 2016169
3 2014143
4 201557
5 202228
6 202328
7 201726
8 201826
9 201724
10 201824
11 202017
12 202515
13 202114
14 202111
15 202210
16 20199
17 20249
18 20218
19 20215
20 20224

About Julia Rey

Julia Rey is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Biochemistry and Aging, having authored 34 papers that have together received 854 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Brain Metastases and Treatment (9 papers), Blood transfusion and management (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Ergonomics and Musculoskeletal Disorders (2 papers), HER2/EGFR in Cancer Research (2 papers), Sports injuries and prevention (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Biochemistry (163 citations), Cancer Research (179 citations), Medical Laboratory Technology (9 citations), Hematology (102 citations) and Oncology (130 citations). Julia Rey has collaborated with scholars based in Germany, Switzerland and Spain. Frequent co-authors include Eva Maria Herrmann, Sibylle Loibl, Carsten Denkert, Peter Andreas Fasching, Valentina Nekljudova, Claus Alexander Hanusch, Jens Huober, Christine Solbach, Michael Untch and Jens‐Uwe Blohmer. Their work appears in journals such as Annals of Oncology, ESMO Open, The Breast, Journal of Occupational Medicine and Toxicology and npj Breast Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact